Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLNX
3701
CALL
DELISTED
Xilinx Inc
XLNX
| $2.31M | ﹤0.01% |
+15,300
| New | +$2.24M |
|
3702
IES Holdings
IESC
$12.3B
| $2.31M | ﹤0.01% |
+100,982
| New | +$2.45M |
|
3703
CarParts.com
PRTS
$55.9M
| $2.31M | ﹤0.01% |
14,779
+1,423
| +11% | +$247K |
|
3704
Lincoln Electric
LECO
$15.5B
| $2.3M | ﹤0.01% |
17,864
+8,110
| +83% | +$1.1M |
|
|
TWOU
3705
CALL
DELISTED
2U Inc
TWOU
| $2.3M | ﹤0.01% |
2,283
-1,520
| -40% | -$1.78M |
|
|
ACB
3706
Aurora Cannabis
ACB
$254M
| $2.3M | ﹤0.01% |
+33,218
| New | +$2.36M |
|
|
FOREU
3707
DELISTED
Foresight Acquisition Corp. Units
FOREU
| $2.3M | ﹤0.01% |
226,306
-37,570
| -14% | -$384K |
|
3708
PUT
Quince Therapeutics
QNCX
$34.3M
| $2.29M | ﹤0.01% |
+125
| New | +$1.99M |
|
|
LFC
3709
DELISTED
China Life Insurance Company Ltd.
LFC
| $2.29M | ﹤0.01% |
280,777
-323,626
| -54% | -$2.77M |
|
|
CYBE
3710
DELISTED
Cyberoptics Corp
CYBE
| $2.29M | ﹤0.01% |
64,336
+8,334
| +15% | +$340K |
|
|
VCRA
3711
CALL
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.29M | ﹤0.01% |
+50,000
| New | +$2.23M |
|
|
HBMD
3712
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $2.29M | ﹤0.01% |
+112,824
| New | +$2.16M |
|
3713
Evertec
EVTC
$1.79B
| $2.29M | ﹤0.01% |
50,025
+1,940
| +4% | +$87.5K |
|
3714
Anavex Life Sciences
AVXL
$277M
| $2.29M | ﹤0.01% |
127,359
+28,391
| +29% | +$565K |
|
3715
Buckle
BKE
$2.24B
| $2.29M | ﹤0.01% |
57,746
-585,463
| -91% | -$25M |
|
3716
Primerica
PRI
$8.94B
| $2.29M | ﹤0.01% |
14,878
-5,226
| -26% | -$778K |
|
|
SLI
3717
Standard Lithium
SLI
$629M
| $2.28M | ﹤0.01% |
+279,674
| New | +$1.85M |
|
3718
Organon & Co
OGN
$3.61B
| $2.27M | ﹤0.01% |
69,328
-349,487
| -83% | -$11.2M |
|
3719
PUT
Darden Restaurants
DRI
$24.5B
| $2.27M | ﹤0.01% |
+15,000
| New | +$2.2M |
|
|
NREF
3720
NexPoint Real Estate Finance
NREF
$325M
| $2.27M | ﹤0.01% |
+116,539
| New | +$2.41M |
|
3721
iShares MSCI China ETF
MCHI
$6.25B
| $2.27M | ﹤0.01% |
+33,600
| New | +$2.42M |
|
3722
Pebblebrook Hotel Trust
PEB
$2.09B
| $2.27M | ﹤0.01% |
101,061
+36,106
| +56% | +$799K |
|
|
FOLD
3723
DELISTED
Amicus Therapeutics
FOLD
| $2.26M | ﹤0.01% |
236,959
+190,124
| +406% | +$1.94M |
|
3724
PUT
Peloton Interactive
PTON
$2.39B
| $2.26M | ﹤0.01% |
26,000
-18,700
| -42% | -$2.07M |
|
|
WW
3725
PUT
DELISTED
WW International
WW
| $2.26M | ﹤0.01% |
124,000
| – | – |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.